Financial Summary (All financials)
| In millions, except per share items | Jan-01-23 | Jan-02-22 | Jan-03-21 |
| Revenues | 3,266.0 | 1,698.6 | 1,661.7 |
| Revenue growth | 92.3% | 2.2% | |
| Cost of goods sold | 1,330.0 | 420.3 | 305.4 |
| Gross profit | 1,936.0 | 1,278.3 | 1,356.3 |
| Gross margin | 59.3% | 75.3% | 81.6% |
| Selling, general and administrative | 621.0 | 239.6 | 180.7 |
| Research and development | 190.5 | 95.7 | 84.3 |
| EBITA | 1,112.2 | 943.0 | 1,091.3 |
| EBITA margin | 34.1% | 55.5% | 65.7% |
| Amortization of intangibles | 132.5 | 27.4 | 27.3 |
| EBIT | 979.7 | 915.6 | 1,064.0 |
| EBIT margin | 30.0% | 53.9% | 64.0% |
| Pre-tax income | 735.9 | 900.3 | 1,040.3 |
| Income taxes | 187.2 | 196.1 | 230.0 |
| Tax rate | 25.4% | 21.8% | 22.1% |
| Net income | 548.7 | 704.2 | 810.3 |
| Net margin | 16.8% | 41.5% | 48.8% |
| |
| Diluted EPS | $9.56 | $16.41 | $18.58 |
| Shares outstanding (diluted) | 57.4 | 42.9 | 43.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|